Jason E. Tester - Net Worth and Insider Trading
Jason E. Tester Net Worth
The estimated net worth of Jason E. Tester is at least $93 Million dollars as of 2024-11-13. Jason E. Tester is the Director, 10% Owner of Tarsus Pharmaceuticals Inc and owns about 1,949,331 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $93 Million. Details can be seen in Jason E. Tester's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason E. Tester has not made any transactions after 2020-10-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason E. Tester
Jason E. Tester Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason E. Tester owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Jason E. Tester’s form 4 insider trades.
Insider Ownership Summary of Jason E. Tester
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | director & 10 percent owner |
Jason E. Tester Latest Holdings Summary
Jason E. Tester currently owns a total of 1 stock. Jason E. Tester owns 1,949,331 shares of Tarsus Pharmaceuticals Inc (TARS) as of October 20, 2020, with a value of $93 Million.
Latest Holdings of Jason E. Tester
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2020-10-20 | 1,949,331 | 47.59 | 92,768,662 |
Holding Weightings of Jason E. Tester
Jason E. Tester Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason E. Tester has made a total of 1 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 171,875 shares on October 20, 2020, which cost Jason E. Tester around $3 Million.
Insider Trading History of Jason E. Tester
- 1
Jason E. Tester Trading Performance
GuruFocus tracks the stock performance after each of Jason E. Tester's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason E. Tester is 92.93%. GuruFocus also compares Jason E. Tester's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason E. Tester within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason E. Tester's insider trading performs compared to the benchmark.
Performance of Jason E. Tester
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.44 | | | | | |
| Relative Return to S&P 500(%) | 5.12 | | | | | |
Jason E. Tester Ownership Network
Ownership Network List of Jason E. Tester
Ownership Network Relation of Jason E. Tester
Jason E. Tester Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Jason E. Tester is the director & 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Jason E. Tester made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 231,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 312,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Jason E. Tester Mailing Address
Above is the net worth, insider trading, and ownership report for Jason E. Tester. You might contact Jason E. Tester via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
